Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at temozolomide and PCV for people with glioma that has come back after treatment (BR12)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Results

Phase:

Phase 3

Details

This trial compared temozolomide (Temodal) with PCV for a type of brain tumour called glioma. This trial was open to people whose glioma had come back after treatment. This trial was supported by Cancer Research UK.

Recruitment start: 18 April 2003

Recruitment end: 4 January 2008

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Michael Brada Professor Siow-Ming Lee

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council (MRC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/01/010.

Last reviewed: 29 June 2014

CRUK internal database number: 4

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.